Key facts
| Price (PPV) | 398 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | rivaroxaban |
| Class | Antithrombotic agents |
| ATC code | B01AF01 |
| Manufacturer | PHARMIS |
| Presentation | Boite de 42 |
| Hospital price | 265 MAD |
| Data collected on | 9/8/2026 |
Indications
- Prévention des thromboses en cas d'interventions orthopédiques majeures des extrémités inférieures telles que prothèse de la hanche ou du genou. - Traitement des thromboses veineuses profondes (TVP) et des embolies pulmonaires (EP) ainsi que prévention des récidives de TVP et d'embolie pulmonaire. - Prévention de l'accident vasculaire cérébral et de l'embolie systémique en présence de fibrillation auriculaire non valvulaire.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Oxarol 15 mg (BOTTU S.A.) contains the same active substance as Rivalto 15 mg (Rivaroxaban) at the same strength, but in a different pack: Boite de 14 at 147 MAD, i.e. 10.50 MAD per unit against 9.48 MAD for Rivalto 15 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Valterio 15 mg | SOTHEMA | Boite de 42 | 398 MAD | 9.48 / unit | — |
| Rexaban 15 mg | AFRIC-PHAR | Boite de 42 | 498 MAD | 11.86 / unit | — |
| Xarelto 15 mg | BAYER S.A | Boite de 42 | 555 MAD | 13.21 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Oxarol 15 mg | BOTTU S.A. | Boite de 14 | 147 MAD | 10.50 / unit |
| Rivalto 15 mg | PHARMIS | Boite de 14 | 147 MAD | 10.50 / unit |
| Valterio 15 mg | SOTHEMA | Boite de 14 | 147 MAD | 10.50 / unit |
| Rexaban 15 mg | AFRIC-PHAR | Boite de 14 | 210 MAD | 15 / unit |
| Xarelto 15 mg | BAYER S.A | Boite de 14 | 215 MAD | 15.36 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Rivalto 15 mg
Rivalto 15 mg belongs to the antithrombotic agents therapeutic class. In Morocco, this drug is marketed by PHARMIS and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Rivalto 15 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Rivalto 15 mg
Answers to common questions from Moroccan patients about this drug.